Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
about
Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbiditiesAtazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic ReviewAtherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.HIV-infection, atherosclerosis and the inflammatory pathway: candidate gene study in a Spanish HIV-infected population.Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease.Privacy-preserving genomic testing in the clinic: a model using HIV treatment.Cardiovascular disease and HIV infection.Risk of coronary heart disease in patients with HIV infection.The relationships among host transcriptional responses reveal distinct signatures underlying viral infection-disease associations.Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.D-Dimer as a prognostic marker of morbidity and mortality among HIV patients: a call for attention.Precision medicine for HIV: where are we?Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review.Myocardial Infarction in HIV-Infected Persons: Time to Focus on the Silent Elephant in the Room?Changes in plasma lipidome following initiation of antiretroviral therapyBritish HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q26853274-E2C42A18-7ABA-407A-A280-161DA2237786Q28080289-4FFDEE82-A339-4222-8F1E-E2C04D93E5FEQ30248286-8FAA161B-FF07-497A-8AEB-6BB82ADBD84DQ30934548-82D18F54-AD3F-4351-B171-21A667878732Q34482615-D8620279-FFFA-4E3D-A60F-B038F38AFF74Q35089263-43946635-BB90-491A-96F6-21DAB2D51D8FQ37176937-CA58B7CD-9108-4608-8AC1-73A442A447AAQ37661603-E3717D3F-CAE7-4A7C-8620-6E2D73D32720Q38261508-790236FC-8430-497F-B325-240D050BFBC2Q38453121-043B5860-2AAC-41BA-B539-92FFB8588D6CQ40450129-359A9680-45CB-4705-A407-FE158C610628Q41048998-C8656E0F-B74F-4A6D-A02D-2F17ADEA6438Q45049681-B51F1558-C2C1-4375-99F6-51F79CB193FAQ47569821-C4149D66-7CB3-4BD1-B5A9-F6760C7B5FFFQ49464137-549F252B-185A-4DAD-A692-049461EA70F3Q56837720-4E546F6D-0AFD-40EB-9768-8B70D6C03374Q57167016-EC8BE136-6225-4A06-8CDB-CC5CD99905E1Q57180790-E28A53B3-82BD-4D92-83DC-5453EF81DA30
P2860
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Contribution of genetic backgr ...... vents in HIV-positive persons.
@en
type
label
Contribution of genetic backgr ...... vents in HIV-positive persons.
@en
prefLabel
Contribution of genetic backgr ...... vents in HIV-positive persons.
@en
P2093
P2860
P50
P356
P1476
Contribution of genetic backgr ...... vents in HIV-positive persons.
@en
P2093
Alan Macken
Alexandra Mangili
Amalio Telenti
Ana Torrecilla-Rodriguez
Andri Rauch
Annalisa Mondi
Antoni Campins
Carlo Torti
Christine A Wanke
Colleen Hadigan
P2860
P304
P356
10.1093/CID/CIT196
P407
P50
P577
2013-03-26T00:00:00Z